New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
08:19 EDTVARVarian Medical receives FDA clearance for Vitesse Brachytherapy treatment
Varian Medical has received an FDA 510k clearance for the latest version of its Vitesse real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.
News For VAR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
09:00 EDTVARVarian Medical price target raised to $99 from $90 at RW Baird
Subscribe for More Information
07:43 EDTVARVarian Medical price target raised to $96 from $87 at Brean Capital
Subscribe for More Information
January 28, 2015
15:37 EDTVARNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use